Longevity.Technology CEO Phil Newman explains our new framework for categorizing and understanding the complexities of longevity.
In September, the Longevity Investors Conference was held in Gstaad, Switzerland; the conference brought together leading scientists, investors and innovators to discuss advancements in longevity science and investment opportunities, and it was also when we unveiled our Ten Levels of Longevity which aims to provide a structured perspective on the multifaceted approaches to enhancing human healthspan and lifespan and reflect the importance of a holistic and tiered understanding in the pursuit of longevity.
The Ten Levels of Longevity framework offers a structured approach to understanding the diverse interventions and strategies aimed at extending human healthspan and lifespan. These levels encompass a spectrum from foundational lifestyle modifications to advanced biomedical therapies, providing a comprehensive roadmap for individuals and professionals navigating the evolving longevity landscape. By categorizing interventions into distinct stages, this framework facilitates clearer communication, targeted research and personalized application of longevity strategies.
One level is no more important than another; a level 7 company is no better than a level 4 company, they are simply just different. As levels progress numerically, they can get more complex and require more capital, and as might be expected, therefore, later levels are further away from market than earlier levels, and there are many earlier level companies already making revenue.
Longevity Now
Level 1: lifestyle management
Active management of diet, sleep, exercise, alcohol intake, smoking, stress, etc. to slow aging disease drivers and prevent aging diseases.
Level 2: consumer diagnostics
Use of biological samples, lifestyle questionnaires, digital information and AI to identify opportunities for both clinical and lifestyle interventions to improve healthspan.
Level 3: longevity supplements
Use of dietary supplements to enhance the metabolism and replace cellular function lost with the progression of age.
Level 4: longevity clinical services
Professional diagnosis of health and aging biomarkers; clinical guidance on lifestyle, diet and therapeutic interventions to mitigate the progression of age.
Level 5: aging disease management
Clinical interventions that manage the symptoms of diagnosed aging diseases (i.e. current mainstream healthcare).
Longevity Next
Level 6: aging disease prevention therapeutics
Clinical interventions that control aging drivers to prevent aging diseases from occurring.
Level 7: targeted aging disease reversal
Therapeutic interventions that stop or reverse age-related damage in specific organs (organ specific / tissue specific / localized reversal) or for age-related diseases.
Level 8: systemic aging reversal
Therapeutic interventions that stop or reverse age-related damage throughout the whole body system.
Level 9: organ/organism preservation or maintenance
Extending human life beyond natural limits. Companies operating at this level focus on developing technologies to replace or repair damaged organs and tissues.
Level 10: corporeal/consciousness preservation
Preservation of the body and/or consciousness for reawakening when approved aging therapeutics and disease cures become available.
